[1]李邦凯,纪浩南,王馨,等.养正消积胶囊辅助GP方案治疗晚期非小细胞肺癌临床研究[J].中国中医药信息杂志,2019,26(8):12-17.[doi:10.3969/j.issn.1005-5304.2019.08.004]
 LI Bangkai,JI Haonan,WANG Xin,et al.Clinical Study on Yangzheng Xiaoji Capsules Combined with GP Regimen in Treatment of Advanced Non-small Cell Lung Cancer[J].zhongguo zhongyiyao xinxi zazhi,2019,26(8):12-17.[doi:10.3969/j.issn.1005-5304.2019.08.004]
点击复制

养正消积胶囊辅助GP方案治疗晚期非小细胞肺癌临床研究

参考文献/References:

[1] 张明云,张菁华,李兴德,等.老年肺癌流行病学及临床治疗现状[J].现代肿瘤医学,2010,18(12):2505-2507.
[2] 韩燕鸿,揭珂,张荷,等.参芪扶正注射液联合GP方案治疗非小细胞肺癌的Meta分析[J].中国实验方剂学杂志,2016,22(8):226-230.
[3] 段秋立.复方斑蝥胶囊治疗非小细胞肺癌的疗效观察[J].中药药理与临床,2016,32(1):191-192.
[4] 李京华,李仝.活血化瘀方联合顺铂治疗晚期非小细胞肺癌临床研究[J].中医学报,2017,32(1):13-17.
[5] 况建荣,余丽娟,刘铮.养正消积胶囊联合化疗治疗晚期非小细胞肺癌的疗效及对患者免疫功能的影响[J].中国处方药,2016,14(1):62-63.
[6] 中华人民共和国卫生部医政司.常见恶性肿瘤诊治规范[M].北京:中国协和医科大学出版社,1999:773-781.
[7] 周际昌.实用肿瘤内科学(第2版)[M].北京:人民卫生出版社,2003:34-35.
[8] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:54-58.
[9] 万崇华,陈明清,张灿珍,等.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355.
[10] SUKARI A, NAGASAKA M, ALHASAN R, et al. Cancer site and adverse events induced by immune checkpoint inhibitors:a retrospective analysis of real-life experience at a single institution[J]. Anticancer Res,2019,39(2):781-790.
[11] 周际昌,谢惠民.新编抗肿瘤药物临床治疗手册[M].北京:中国协和医科大学出版社,2004:237-386.
[12] LE P C. Role of postoperative radiotherapy in resected non-small cell lung cancer:a reassessment based on new data[J]. Oncologist,2011,16(5):672-681.
[13] 徐立群,张荣华,邹莹,等.参慈胶囊联合顺铂通过PI3K/AKT/mTOR信号通路逆转人肺腺癌顺铂耐药的机制研究[J].中国病理生理杂志, 2017,33(3):500-504.
[14] 王永顺,王延涛,纪雪华.吉西他滨单药治疗老年晚期非小细胞肺癌的临床观察[J].中国现代医生,2010,48(13):139,141.
[15] 尹梅,赖寒,罗朝朗,等.吉西他滨单药治疗老年晚期非小细胞肺癌的临床观察[J].肿瘤药学,2014,4(3):197-198.
[16] KANG S, KOH E S, VINOD S K, et al. Cost analysis of lung cancer management in South Western Sydney[J]. J Med Imaging Radiat Oncol,2012,56(2):235-241.
[17] 李军,王晓敏,宋张骏,等.非小细胞肺癌中Ki-67和BCL-2表达的临床意义及预后价值[J].临床与实验病理学杂志,2012,28(8):921-924.
[18] INOUE-YAMAUCHI A, JENG P S, KIM K, et al. Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy[J]. Nat Commun,2017,8:16078.
[19] 马家宝,朱文,周清华.bag-1、bcl-2和bax在非小细胞肺癌中的表达和意义及其与化疗多药耐药相关性的研究[J].中国肺癌杂志,2009, 12(10):1089-1094.
[20] KIM C, LEE H S, PARK J, et al. Prognostic role of p53 and Ki-67 immunohistochemical expression in patients with surgically resected lung adenocarcinoma:A retrospective study[J]. Journal of Thoracic Disease,2015,7(5):822-833.
[21] DOWSETT M, NIELSEN T O, A’HERN R, et al. Assessment of Ki67 in breast cancer:recommendations from the International Ki67 in Breast Cancer Working Group[J]. J Natl Cancer Inst,2011,103(22):1656-1664.

相似文献/References:

[1]杨国旺,富琦,徐咏梅,等.晚期非小细胞肺癌患者凝血指标的临床分析[J].中国中医药信息杂志,2009,16(6):19.
 YANG Guo-wang,FU Qi,XU Yong-mei,et al.Clinical Analysis on Coagulation Markers in Advanced NSCLC Patients[J].zhongguo zhongyiyao xinxi zazhi,2009,16(8):19.
[2]周雍明,朴炳奎,侯炜,等.肺瘤平膏改善非小细胞肺癌患者免疫状态及预后的临床观察[J].中国中医药信息杂志,2008,15(5):78.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(8):78.
[3]宋翠萍.艾迪注射液联合化疗治疗晚期非小细胞肺癌临床观察[J].中国中医药信息杂志,2008,15(7):64.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(8):64.
[4]刘秀芳,李凤玉,王炳胜,等.益气活血中药对肺癌放疗患者肺功能的影响[J].中国中医药信息杂志,2008,15(8):16.
 LIU Xiu-fang,LI Feng-yu,WANG Bing-sheng,et al.Effect of Yiqi Huoxue Recipe on Pulmonary Function of Lung Cancer Patients after Radiation Therapy[J].zhongguo zhongyiyao xinxi zazhi,2008,15(8):16.
[5]张培新,陈坤,王春雨.复方苦参注射液联合化疗治疗中晚期非小细胞肺癌50例[J].中国中医药信息杂志,2008,15(8):63.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(8):63.
[6]杨宗艳,林洪生,李道睿.单纯中药和单药化疗治疗老年晚期非小细胞肺癌临床研究[J].中国中医药信息杂志,2008,15(8):79.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(8):79.
[7]龚志敏,王言,余川运,等.参芪扶正注射液配合NP方案化疗治疗老年晚期非小细胞肺癌疗效观察[J].中国中医药信息杂志,2008,15(9):64.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(8):64.
[8]解建国,阳其绢,何丰华,等.肺癌1号方对晚期非小细胞肺癌患者免疫功能及血清VEGF、CYFRA21-1的影响[J].中国中医药信息杂志,2008,15(11):9.
 XIE Jian-guo,YANG Qi-juan,HE Feng-hua,et al.Effect of Lung Cancer Fang No.1 on Immune Function and Serum VEGF, CYFRA21-1 in Advanced Non-Small Cell Lung Cancer Patients[J].zhongguo zhongyiyao xinxi zazhi,2008,15(8):9.
[9]庄炜,李莉,湛韬,等.康艾注射液联合TP化疗方案治疗非小细胞肺癌的Meta分析[J].中国中医药信息杂志,2011,18(5):29.[doi:10.3969/j.issn.1005-5304.2011.05.011]
 ZHUANG Wei,LI Li,ZHAN Tao,et al.Meta-analysis of Kang Ai Injection Together with TP Model Chemotherapy for Treatment of Non-small Cell Lung Cancer[J].zhongguo zhongyiyao xinxi zazhi,2011,18(8):29.[doi:10.3969/j.issn.1005-5304.2011.05.011]
[10]冯利,花宝金,朴炳奎.肺瘤平Ⅱ号改善肺癌患者生存质量临床研究[J].中国中医药信息杂志,2006,13(12):12.
 FENG Li,HUA Bao-Jin,PIAO Bing-Kui.Clinical Study of Feiliuping Ⅱ on Quality of Life of Lung Cancer Patients[J].zhongguo zhongyiyao xinxi zazhi,2006,13(8):12.

备注/Memo

基金项目:福建省卫生厅中医药科研专项课题(wst201210)

更新日期/Last Update:

2019-07-15